MS — PERHAPS The "Experts" Got It Wrong

When the Cure Might Be the Cause: Rethinking Parasites and Autoimmune Disease

What if the story we've been told about parasites and autoimmune disease is only half the picture?

The research is genuinely fascinating. Studies have shown that people living in regions with higher rates of parasitic infections tend to have significantly lower rates of multiple sclerosis. A landmark study by Correale and Farez showed that patients with MS who naturally acquired helminth infections experienced dramatically fewer relapses. The working theory—often called the Hygiene Hypothesis—is that our increasingly sanitized modern world has left our immune systems without a familiar sparring partner, so they turn inward and attack us instead.

It's a compelling argument. But here's where I find myself lingering.

Because nobody seems to be asking a pretty obvious question about that geographic data. The regions most often cited for lower MS rates — parts of Latin America, sub-Saharan Africa, Southeast Asia — aren't just places where people happen to have more parasites. They're also places where antiparasitic drugs like ivermectin are distributed widely.

So are these populations actually hosting more parasites? Or are they regularly clearing them?

That's not a small distinction. That completely reframes the hypothesis. What if it's the periodic clearing of parasites that's protective — not chronic infection itself?

And then there's the question of what happens when you try to clear parasites that have been there a long time. Aggressive parasite cleanses have become increasingly popular, but forcing a rapid die-off could theoretically drive inflammation exactly where you least want it. We see evidence of this in neurocysticercosis research, where the destruction of parasites in the brain can cause severe, acute inflammation that requires steroid management.

The Herxheimer reaction — that brutal temporary worsening when pathogens are killed off quickly — is well documented in conditions like Lyme disease. Why wouldn't something similar apply here? Could some of what gets labeled as an MS relapse actually be the body responding to something being disturbed rather than something breaking down on its own?

Ivermectin's own biological effects are increasingly being studied beyond its antiparasitic action. Research into its role as an immune modulator and anti-inflammatory agent suggests it might be doing something to immune calibration that we don't yet have good language for. These threads deserve to be pulled.

Mainstream medicine is not having this conversation. At least not yet.

I'll keep pondering. And reading. And sitting with questions that don't have clean answers — because those are usually the ones worth asking.